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Background. The Arclight ophthalmoscope is a low-cost alternative to standard direct ophthalmoscopes. This study compared the
Arclight ophthalmoscope with the Heine K180 direct ophthalmoscope to evaluate its reliability in assessing the vertical cup disc
ratio (VCDR) and its ease of use (EOU).Methods. Eight medical students used both the Arclight and the Heine ophthalmoscopes
to examine the optic disc in 9 subjects. An EOU score was provided after every examination (a higher score indicating that the
ophthalmoscope is easier to use). A consultant ophthalmologist provided the reference standard VCDR. Results. 288 examinations
were performed. The number of examinations that yielded an estimation of the VCDR was significantly higher for the Arclight
ophthalmoscope (125/144, 85%) compared to the Heine ophthalmoscope (88/144, 61%) (𝑝 < 0.001). The mean difference from
the reference standard VCDR was similar for both instruments, with a mean of −0.078 (95% CI: −0.10 to −0.056) for the Arclight
and −0.072 (95% CI: −0.097 to −0.046) for Heine (𝑝 = 0.69). The overall EOU score was significantly higher for the Arclight
ophthalmoscope (𝑝 < 0.001). Conclusion. The Arclight ophthalmoscope performs as well as, and is easier to use than, a standard
direct ophthalmoscope, suggesting it is a reliable, low-cost alternative.
1. Introduction
Vision 2020 is the global initiative, launched in 1999 by the
World Health Organization (WHO) and the International
Agency for the Prevention of Blindness (IAPB), with the aim
of eliminating avoidable blindness. In the African region,
WHO estimates that 26 million people are visually impaired
and 6 million people are blind [1]. Significant progress has
already beenmade in treating or preventing anterior segment
eye diseases such as cataract and trachoma and an increasing
proportion of the remaining burden of avoidable blindness
in sub-Saharan Africa (SSA) is attributable to diseases of
the back of the eye, particularly glaucoma and diabetic
retinopathy [2].
The International Diabetes Federation predicts that the
number of adults with diabetes in Africa will double from 12
million in 2010 to 24million in 2030 [3]. Diabetic retinopathy
is the commonest microvascular complication of diabetes [4]
and, globally, is the leading cause of blindness in adults of
working age [5].The number of people in SSAwith glaucoma
was estimated to be 6.5 million in 2010 and is anticipated to
increase to 8.4 million by 2020 [6]. Although no cure exists
for glaucoma or diabetic retinopathy, early detection and
timely management can help slow progression and improve
prognosis [7, 8].
In many SSA countries the per capita number of oph-
thalmologists and the prevalence of blindness are inversely
correlated; the former concentrated in major urban areas
and the latter in poorer rural regions [9]. In addition to
this, the overall numbers of eye health personnel are below
that which is needed. The regional ratio of ophthalmologists
in SSA is 2.3 per million population [10]. For example, in
Malawi there are seven consultant ophthalmologists serving
a population of 15.2million [11].Therefore, general healthcare
workers, opticians, and allied eye care professionals often
review patients with eye diseases.These groups need access to
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equipment and adequate training to allow them to examine
and detect pathology in the posterior segment of the eye.
However, standard direct ophthalmoscopes are expensive,
ranging from USD $200 to 600 per instrument.
The Arclight ophthalmoscope (http://www.arclightscope
.com; Figure 1) provides a low-cost alternative to standard
direct ophthalmoscopes. It is marketed at USD $7.50 when
sold in bulk. It has a small direct ophthalmoscope at one end
with an illuminating magnifying loupe (allowing examina-
tion of the anterior segment) and a detachable otoscope at the
other end. It weighs 18 grams, uses three LED light sources,
and has an inbuilt rechargeable battery powered by either
an integrated solar panel (useful for mobile clinics in sub-
Saharan Africa) or a USB port. The device has an adjustable
lens slider with three different lenses, allowing for a rough
correction of the patient’s or examiner’s refractive error. The
device also incorporates a small colour vision test, a near
visual acuity chart, a ruler, and a pupil size gauge.
The aim of this study was to assess if the Arclight
ophthalmoscope performs as well as a conventional direct
ophthalmoscope in the hands of final-year medical students
(representative of nonspecialist users) in terms of estimating
the vertical cup : disc ratio (VCDR) and its ease of use (EOU),
in order to evaluate Arclight as an alternative to the standard
direct ophthalmoscope. The VCDR was chosen as it is a
clinically important measure in the assessment of glaucoma.
The disc is a central and easily identifiable structure with
sufficient variation in cup : disc ratios to provide numerical
data for formal analysis [12, 13].
2. Materials and Methods
The study was approved by the Research Ethics Review
Committee at Kilimanjaro Christian Medical University
College (KCMUC), Moshi, Tanzania. It was conducted in
the Department of Ophthalmology at Kilimanjaro Christian
Medical Centre (KCMC). Written informed consent was
provided by all participants.
In this study we compared the Arclight ophthalmoscope
to the Heine K180 in terms of four measures: (1) accuracy of
VCDR assessment, (2) ease of use (EOU) for the examiner
using a score of 1–8 (Table 1), (3) the level of glare experienced
by the subject using a score of 1–4 (Table 1), and (4) the
perceived duration of the assessment using a score of 1–4
(Table 1) and scored by the subject as well. For measures (2)
to (4) higher scores indicated better results.
Eight final-year medical students performed the exami-
nations. To ensure a similar level of experience in ophthal-
mology, students who had taken more than one undergrad-
uate course in ophthalmology were excluded. Students with
a refractive error exceeding the corrective lenses of Arclight
(−6 to +4) were also excluded. An introductory “refresher”
session on direct ophthalmoscopy with particular reference
to examination of the optic disc and assessment of the VCDR
was provided. Following this, the examiners had a short
practice session to familiarize themselves with both devices.
Nine healthy volunteers (18 eyes) acted as subjects and
eachwas examined by the eightmedical students. All subjects
had one eye dilated at random using tropicamide 1% eye
Direct ophthalmoscope
Red desaturation test
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staining examination
Illuminating magnifying
×4 lens
USB charger port
Solar panel
Otoscope adapter
Figure 1:TheArclight direct ophthalmoscope with selected features
highlighted.
Table 1: Examination scales: (a) ease of use (examiner), (b) comfort
scale (subject) and (c) length of examination (subject).
(a) Ease of use
(1) Could not use at all
(2) Could not see the red reflex to even begin with
(3) Could identify red reflex
(4) Could see vessels but not disc
(5) Could identify disc but not vertical CD-ratio
(VCDR)
(6) Could determine VCDR with a high level of
difficulty
(7) Could determine VCDR with a medium level
of difficulty
(8) Could determine VCDR with a low level of
difficulty
(b) Comfort
scale
(1) Uncomfortable glare
(2) Significant glare
(3) Some glare
(4) No glare
(c) Length of
examination
(1) Uncomfortably long
(2) Long examination time
(3) Average examination time
(4) Short examination time
drops. Therefore, half of the examinations were performed
on a dilated pupil. Each examiner assessed both eyes of each
volunteer subject with both devices. They were randomly
assigned to start with an Arclight or Heine ophthalmoscope.
Examinations were conducted in two circuits. In the first
circuit the examiners examined both eyes of each subject
using either theArclight or theHeine ophthalmoscope. In the
second circuit the examiners changed ophthalmoscopes and
reexamined both eyes of each subject. Within each circuit,
all the right eyes were examined first, followed by all the left
eyes. This was done as we recognized that there could be a
tendency, because of the normal symmetry between eyes, not
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Figure 2: Bland-Altman plots showing the difference between the examiner’s estimate of vertical cup : disc ratio (VCDR) and the reference
standard, split by instrument. Plot (a) represents the Arclight direct ophthalmoscope and plot (b) represents the Heine K180 direct
ophthalmoscope. Where there is exact agreement between the examiner and the reference standard the difference in VCDR is noted as
0. Any deviation from 0 represents underestimation (if negative) or overestimation (if positive) of the VCDR compared with the reference
standard. The horizontal dotted line represents the mean of all observations (i.e., their mean deviation from the reference standard), and the
grey area represents the proportion of all observations lying within 95% of the normal distribution for each of the two ophthalmoscopes.The
size of each black dot is proportional to the number of observations it represents.
to grade the eyes in an independentmanner [14]. A consultant
ophthalmologist (HP), with a specialty interest in glaucoma,
examined each subject with theHeine direct ophthalmoscope
to provide the “reference standard” for VCDR measurement.
Data were recorded at the end of each examination by
both the examiner and the subject. The examiner recorded
theVCDR (range: 0.0 to 1.0) and an ease of use score (Table 1).
The subject recorded the level of glare experienced and an
impression of the length of the examination (Table 1).
Statistical analysis was performed using Student’s t-test
to compare differences between examiners’ VCDR measure-
ments and the reference standard. A Bland-Altman plot
was calculated for both devices to provide a visual guide
to the differences between examiners’ VCDR scores and
the “reference standard.” STATA version 13 was used to
compute statistics and graphs. A chi-squared test was used
to compare the proportion of examinations that yielded
an estimation of the VCDR with the Arclight versus the
Heine ophthalmoscope. Ease of use, “glare,” and “length of
examination” were analyzed using chi-squared andWilcoxon
rank-sum tests.
3. Results and Discussion
3.1. Results
3.1.1. VCDR Estimation. Each examiner performed 36 exam-
inations (18 with the Arclight ophthalmoscope and 18 with
the Heine ophthalmoscope, 9 dilated and 9 undilated eyes
each), resulting in a total of 288 examinations. In total, 213
(74%) examinations resulted in an estimate of the VCDR.
Significantly more of the Arclight examinations (125/144
[85%]) compared to the Heine ophthalmoscopes examina-
tions (88/144 [61%]) produced a VCDR measure (𝜒2, 𝑝 <
0.001). For both devices significantly more VCDR estimates
were possible through examination of dilated pupils: 71/125
(57%) for the Arclight (𝜒2, 𝑝 < 0.001) and 58/88 (66%) for
the Heine (𝜒2, 𝑝 < 0.001).
There was a very small difference between the reference
standard VCDR measure and the Arclight measurements:
mean difference −0.078 (95% CI: −0.10 to −0.056). There
was a similar, very small difference for the comparison
between the reference standard and Heine ophthalmoscope
measurements: mean difference −0.072 (95% CI: −0.097 to
−0.046). There was no difference in this mean performance
between the two measures (𝑝 = 0.69). Bland-Altman
plots were constructed for the difference in VCDR estimates
between examiners and the reference standard (Figure 2).
Separate subanalyses of dilated and undilated pupils
had similar results. For dilated pupils, the mean difference
between the reference standard VCDR and the Arclight mea-
surement was −0.087 (95% CI: −0.057 to −0.12) compared
to −0.084 (95% CI: −0.053 to −0.12) for the Heine oph-
thalmoscope, with no difference between ophthalmoscopes
(𝑝 = 0.9). For undilated pupils, the mean difference between
the Arclight measurement and the reference standard was
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−0.067 (95% CI: −0.033 to −0.10) compared to −0.047 (95%
CI: −0.004 to −0.089) for theHeine ophthalmoscope, with no
difference between ophthalmoscopes (𝑝 = 0.47).
The total number of examinations that yielded a ≥0.2
difference in the VCDR from the reference standard was
37/125 (29.6%) and 25/88 (28.4%) for the Arclight and Heine
ophthalmoscopes, respectively (𝜒2, 𝑝 = 0.85). A random
effects model was performed which showed no significant
between-cluster variation between the two eyes.
3.1.2. Ease of Use. An ease of use score was obtained for all
288 examinations.The overall median score was significantly
higher (Wilcoxon rank-sum, 𝑝 < 0.001) for the Arclight
(median 7, IQR 6 to 8) than the Heine (median 6, IQR 5
to 7), Figure 3. Both devices had higher EOU scores for
dilated pupils: Arclight median score 7 (IQR 7-8) for dilated
eyes versus 7 (IQR 5.75–7) for undilated pupils (Wilcoxon
rank-sum, 𝑝 < 0.001) and Heine median score 7 (IQR 6-
7) versus 5 (IQR 5-6) (Wilcoxon rank-sum, 𝑝 < 0.001)
for dilated and undilated eyes, respectively. There were no
significant differences in EOU scores between the first and
second circuits.
3.1.3. Examination Comfort. Subject-rated “glare” and
perceived “length of examination” data were obtained
for 285/288 examinations. Responses were missing for
three examinations. Participants reported significantly more
“glare” from theHeine ophthalmoscope (𝑝 = 0.046): Arclight
median score 3 (IQR 3-3), Heine median score 3 (IQR 2-3)
(Figure 4). Similarly, participants reported significantly
longer examinations for the Heine ophthalmoscope (𝑝 <
0.001): Arclight median score 3 (IQR 3-4), Heine median
score 3 (IQR 2-3) (Figure 5). There were no significant differ-
ences in subject-rated “glare” between dilated and undilated
pupils. However, subjects reported a significantly shorter
“length of examination” when dilated pupils versus undilated
pupils were examined (𝑝 < 0.001). This difference was also
apparent when each device was compared separately.
3.2. Discussion. The Arclight ophthalmoscope aims to pro-
vide a reliable, low-cost alternative to the standard direct
ophthalmoscope. We found no evidence of a difference
between the Arclight ophthalmoscope and the Heine K180
direct ophthalmoscope in terms of accuracy of the VCDR
measurement, performed by final-year medical students.
However, the students found the Arclight significantly easier
to use. We also found no clinically significant differences
between the devices, with a similar proportion of exami-
nations yielding a ≥0.2 difference in the VCDR compared
to the reference standard for both the Arclight and Heine
ophthalmoscopes.
Importantly, 85% of Arclight examinations yielded a
VCDR estimation, compared to 61% with the Heine oph-
thalmoscope. This provides an additional indication that the
Arclight ophthalmoscope is easier to use with added clinical
benefits. From a patient perspective, the LED bulb in the
Arclight ophthalmoscope resulted in a subjectively more
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Figure 3: A histogram of the frequency of ease of use score for the
Arclight and Heine direct ophthalmoscopes. 3: could identify red
reflex. 4: could see vessels but not disc. 5: could identify disc but not
vertical CD-ratio (VCDR). 6: could determine VCDR with a high
level of difficulty. 7: could determine VCDR with a medium level of
difficulty. 8: could determine VCDR with a low level of difficulty.
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Figure 4: A histogram of the frequency of brightness reported by
those examined for the Arclight and Heine direct ophthalmoscopes.
comfortable examination, with significantly lower scores for
both “glare” and “length of examination.”
The cost of an Arclight ophthalmoscope is considerably
lower thanHeine K180 direct ophthalmoscope or comparable
instruments. For the current price of Heine direct ophthal-
moscope (USD $365), one can buy 48 Arclight ophthalmo-
scopes at their marketed bulk order price (USD $7.5).
Arclight is the first direct ophthalmoscope to be specifi-
cally designed for low-income settings. However, it also has
a potential application to training and education globally
by providing a more affordable direct ophthalmoscope for
students. In contrast to other low-cost direct ophthalmo-
scopes [13, 15], the Arclight has an adjustable lens power
with three settings (+4, −3, and −6 dioptres). This simple
adjustment will compensate for most patient and examiner
refractive error. It also has an additional function as an
Journal of Ophthalmology 5
Uncomfortably
Arclight
Heine
0
20
40
60
Fr
eq
ue
nc
y
Long
time
Average
time
Short
time
long examination examination examination
Figure 5: A histogram showing the subjective length of examination
reported by those examined for the Arclight and Heine direct
ophthalmoscopes.
otoscope in combination with the provided attachable device
(Figure 1).
The human resources situation in SSA means that large
numbers of patients are seen in rural areas or inmobile clinics
by allied eye health professionals who often have limited
access to equipment and training, making examination of
the posterior segment of the eye impossible [10]. Due to
its low cost, Arclight has the potential to be much more
widely available, hence improving training opportunities and
allowing examination of the optic disc more routinely. This
will aid the early detection of glaucomatous disc changes.
The earlier the glaucoma is detected and managed the better
the prognosis with a reduced likelihood of progression to
blindness is. The solar powered battery of the Arclight
ophthalmoscope offers a further advantage for remote, rural
clinics enabling the Arclight ophthalmoscope to be easily
recharged in rural areas without access to power and also
avoiding the expense of replacing batteries.
Although this study did not assess the accuracy of
the Arclight ophthalmoscope in detecting abnormalities in
the retina, it is possible that it could be used to detect
diabetic retinopathy. The effective management of diabetic
retinopathy in SSA will need a coordinated effort and faces
multiple challenges. Burgess et al. highlighted a number of
these including lack of training for opticians and other eye
care workers in fundoscopy as well as poor equipment [11].
Arclight has the potential to help with both these challenges
through greater access to direct ophthalmoscopes; however,
this will need to be formally evaluated.
One of the limitations of our study was that all the
eyes examined were healthy. It is therefore not possible to
comment on how Arclight will perform in the presence
of pathology. In everyday clinical practice it is clear that
pathology such as cataract will be common, especially in low-
income settings, and will generally make the examination of
the posterior segment more difficult.
In conclusion, the Arclight ophthalmoscope provides a
low-cost alternative to the standard direct ophthalmoscope.
It is easier to use and more comfortable for the subject. It
appears to provide comparable results when examining the
VCDR. It has the potential to significantly improve access
to equipment in low-income settings around the world. This
could improve fundoscopy amongst eye care workers and
enable routine examination of the posterior segment of the
eye, which is an area that is becoming increasingly important
in SSA. Further studies assessing the reliability of the Arclight
ophthalmoscope in diabetic retinopathy detection and in the
presence of other pathology would be useful.
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